Coronary Arterial Disease (CAD)ParaDoxNCT06919237
Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardiorespiratory Fitness in Coronary Artery Disease
A study testing HIIT Intervention, MICT Intervention and HRV-Guided Intervention in people with Coronary Arterial Disease (CAD), run by Faculdade de Motricidade Humana at 1 site in Portugal.
Trial summary
Coronary artery disease (CAD) is associated with autonomic dysfunction and is characterized by reduced heart rate variability (HRV) and impaired heart rate recovery. Regular exercise improves cardiovascular outcomes in CAD, with high-intensity interval training (HIIT) showing superior benefits compared to… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Coronary Arterial Disease (CAD)
- What is being tested?
- HIIT Intervention, MICT Intervention and HRV-Guided Intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 48 participants
- Where
- 1 sitePortugal
- Study dates
- 1 Sep 2025to 1 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- aged over 18 years;
- had angiographically documented CAD in at least one major epicardial vessel;
- clinical evidence of CAD in the form of previous myocardial infarction;
- clinical evidence of CAD in the form of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention);
- clinical evidence of CAD in the form of angina pectoris.
Who cannot join
- heart failure;
- cardiac implantable defibrillators;
- resynchronizing devices;
- inability to comply with guidelines for participation in exercise testing and training.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Portugal1 site
Faculdade de Motricidade Humana
Lisbon, Lisbon District, 1495-688
About this study
Official title: Chronic Adaptations in Cardiovagal Modulation and Cardiorespiratory Fitness in Patients With Coronary Artery Disease to a 12-week Heart Rate Variability-guided Training vs Traditional Aerobic Prescription Program: Study Protocol for a Randomized Controlled Trial
Coronary artery disease (CAD) is associated with autonomic dysfunction and is characterized by reduced heart rate variability (HRV) and impaired heart rate recovery. Regular exercise improves cardiovascular outcomes in CAD, with high-intensity interval training (HIIT) showing superior benefits compared to moderate-intensity continuous training (MICT). However, the full potential of exercise is not used in the clinical context since some of the training principles are neglected, contributing to a high number of exercise non-responders. HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise and has contributed to greater improvements compared to standard prescriptions. Thus, this study aims to assess the chronic effects of exercise on cardiovagal modulation, baroreflex sensitivity, arterial stiffness, and cardiorespiratory fitness in patients with CAD, specifically determining whether heart rate variability-guided training yields different outcomes compared to a traditional prescription in a 12-week exercise intervention.
A total of 48 participants, will be recruited and randomized into one of 3 groups: high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), and HRV-guided training. The intervention will consist of 12 weeks of supervised exercise, with 3 weekly sessions. Participants in the HRV-guided training group will have their exercise intensity adjusted based on their individual HRV profiles. Moderate- or high-intensity sessions are prescribed when the 7-day rolling average of LnRMSSD remains within the smallest worthwhile change (SWC). If it falls outside the SWC, low-intensity sessions or rest are recommended. In the HIIT group, sessions will consist of 4 bouts of 2 minutes at 80-90% HRR during the first 4 weeks, increasing to 6 bouts of 2 minutes at the same intensity in weeks 5-8, and progressing to 6 bouts of 2 minutes at 90% HRR in the final 4 weeks. In the MICT group, participants will perform continuous sessions starting with 2x10 minutes at 50-60% HRR in the first 4 weeks, progressing to 2x12 minutes at the same intensity in weeks 5-8, and increasing to 2x15 minutes at 60-70% HRR in the final phase. Cardiovagal modulation, cardiorespiratory fitness, BRS, and AS will be assessed at the baseline and after the 12 weeks of intervention.
Most cardiac rehabilitation programs use the "one-size-fits-all" approach, which is a limitation of the literature, leading to a large number of exercise nonresponders to changes in cardiorespiratory fitness. HRV-guided training seems to be a more individualized method of aerobic prescription and may lead to greater improvements in cardiorespiratory fitness and in cardiovagal modulation. This study will contribute to generate evidence regarding aerobic exercise prescription in cardiac rehabilitation.
Read the detailed description
Background
Coronary artery disease (CAD) is characterized by the inability to adequately supply blood and oxygen to the heart, often resulting from the formation of atherosclerotic plaques within the arterial lumen. This inflammatory, multifactorial condition can impair the autonomic nervous system (ANS), disrupting the balance between the sympathetic and parasympathetic pathways and leading to autonomic dysfunction. Key indicators of this dysfunction include reduced heart rate variability (HRV) and delayed heart rate recovery, both of which signify heightened sympathetic activity and diminished parasympathetic activity. These changes predict worse cardiovascular outcomes in CAD patients, as the ANS compensates for myocardial ischemia and hypoxia by increasing sympathetic drive and reducing vagal activity to preserve cardiac contractility and output. This imbalance triggers a cascade of neurohumoral alterations affecting the cardiovascular, peripheral vascular, and renal systems, further exacerbating disease progression.
Regular exercise is known to play an important role in the prevention, management, and treatment of CAD, mainly through the preservation of endothelial function but also through the improvement of cardiovagal modulation and neurocardiovascular stress reactivity and by the increase in cardiorespiratory fitness. Patients with stable CAD should undergo a cardiac rehabilitation program to fulfill exercise guidelines. Protocols may vary in mode, intensity, frequency, and duration, whereas the most recommended types of exercise are walking and cycling, with intensities between 40-80% of VO2peak associated with increases in exercise capacity by 11-36%. Recent studies demonstrated that high-intensity interval training (HIIT) compared with moderate-intensity continuous training (MICT) promotes higher adaptation in VO2max and in post-exercise heart rate recovery, HIIT has also demonstrated to contribute to the restoration of endothelial function and autonomic balance, inducing reverse cardiac remodeling and increasing left ventricle morphology and function. However, MICT demonstrates higher adherence because it is a safer and more effective approach. Nevertheless, despite the known non-pharmacological benefits of exercise, recent studies demonstrate that more than 15% of the patients with CAD are exercise non-responders to increases in VO2max , i.e., an increase of 3.5 ml/kg/min in VO2max, which has been associated with a 10% decrease in all-cause of mortality and cardiovascular mortality, however the greater the increases in VO2max the greater the reduction in the risk.
Exercise individualization is increasing among apparently healthy populations due to the ease of the use of cellphone applications. Recently, HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise prescription, this prescription technique demonstrated to contribute to greater improvements in endurance athletes. HRV-guided training concerns to exercise prescribed based on daily changes in HRV, depending on thresholds constructed at the individual level. After an initial characterization period, where the HRV after waking up is measured, the individual HRV profile is defined. Then, considering the resting values of HRV, exercise intensity will be determined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (+), high-intensity or moderate-intensity training sessions is prescribed, and if LnRMSSD7day-roll-avg fell outside SWC (-), low intensity or rest is prescribed. This prescription technique leads to different workloads from the predefined training programs.
To the best of our knowledge, no study has yet compared the chronic effects of two different exercise protocols on cardiovagal modulation, and cardiorespiratory fitness in patients with CAD. Thus, this research aims to compare the chronic adaptations on cardiorespiratory fitness, cardiovagal modulation, baroreflex sensitivity (BRS), and arterial stiffness (AS) of two different techniques of exercise prescription (traditional vs individualized) and two training methods (HIIT vs MICT) in patients with CAD. We hypothesize that exercise individualization will promote higher adaptations in cardiovagal modulation, cardiorespiratory fitness, BRS and AS in patients with CAD, compared with traditional prescription.
Methods
Study design This longitudinal randomized trial will consist of comparing the effects of different exercise prescription techniques and different methods of exercise prescription (traditional MICT, traditional HIIT, and HRV-guided training) would exhibit differences in chronic adaptations in cardiorespiratory fitness, cardiovagal modulation, and BRS in patients with CAD. The study will consist of 12 weeks of supervised exercise with 3 sessions per week. This study protocol was submitted to the Faculty of Human Kinetics Institutional Review Board.
Sample size
Assuming a change in VO2max of 3.5 mL/kg/min to be clinically relevant, α = 0.05, 1-β = 0.80, an expected dropout of 15% for 12 weeks, and a chosen medium effect size of 0.25 due to gaps in the literature, the calculations yielded a total minimum of 48 participants (16 per group) (G*Power, version 3.1.9.4), however, the sample size will be updated, if necessary, after a pilot study consisting of 12 participants, 4 per group, (48x0.25=12).
Recruitment
Recruitment will be performed mainly at the Coronary Club of Lisbon (CORLIS) (phase III) at the Faculty of Human Kinetics and at the Hospital of Santa Cruz in Lisbon.
Measurements
All study measurements will be collected at the Faculty of Human Kinetics, University of Lisbon. Assessments of cardiopulmonary exercise test (CPET), cardiovagal modulation, body composition, and arterial stiffness, will be conducted both at baseline and after the 12-week intervention period. Participants will be requested to be fasted (> 4h), abstain from foods/drinks containing caffeine and alcohol (> 12h), and refrain from strenuous exercise (> 24h) before assessments, post-intervention assessments will be scheduled for the same time that baseline. The measures will follow the following order body composition, cardiovagal modulation (and baroreflex sensitivity), local and regional arterial stiffness, cardiopulmonary test, and post-maximal exercise cardiovagal modulation (and baroreflex sensitivity), and local and regional arterial stiffness.
Randomization
Baseline evaluation will be done before randomization, thus neither participants nor fieldwork staff will know the group assignment at this point. Due to the nature of the intervention, it will not be possible to blind participants after baseline assessments. After the baseline assessments, block randomization by group with balanced blocks of 12 participants will be performed by a researcher not involved in recruitment or data collection using REDCap (https://imm.medicina.ulisboa.pt/group/redcap/redcap_v7.6.7/). The participants will be randomly allocated to one of the three groups: HIIT, MICT, and HRV-guided training.
Exercise intervention
Exercise intervention will have a 12-week duration, with 3 sessions per week on non-consecutive days for all 3 groups and will be carried out at the Faculdade de Motricidade Humana. Certified exercise physiologists will supervise sessions. Heart rate will be monitored during all sessions with an HR monitor (S810i Polar, Polar Electro, Kempele, Finland; sampling rate 1000 Hz). All sessions will include a 10-minute warm-up, an aerobic component, a strength component, and a cool-down for both groups. The warm-up will focus on increasing HR, improving mobility, and performing preparatory stretches for the conditioning component. The strength component will consist of 6 arm and 2 leg machines with 2 sets of 8 to 12 reps at 50-60% 1RM per machine. The cool-down will transition from the conditioning component to the stretching phase, consisting of static and dynamic stretching exercises for all major muscle groups. Warm-up, strength component and coold-down will be standardized for the 3 groups. Sessions will be deemed completed when at least 83.3% (30 out of 36 sessions i.e. minimum adherence = 83.3%) of the prescribed exercise sessions have been successfully performed (reached the programmed intensity). The aerobic component in all groups will follow linear periodization. Volume and/or intensity will increase every 4 weeks.
Data analysis
All HRV analyses will be performed offline using the FisioSinal software built-in Matlab [25]. Time-domain and spectral power analyses will be conducted using 2-min time bins. Ectopic heartbeats (M = 1, SD = 4 b.min-1) will be excluded from the final analysis. The time-domain statistics used to characterize HRV will be SDNN and RMSSD. Non-linear time-domain parameters will be derived from the Poincaré plot including SD1 and SD2. The time-frequency domain analysis will be conducted using the Daubechy-12 discrete wavelet algorithm. Wavelet analysis will be chosen instead of fast Fourier transform as it is better suited to characterize the acute responses of the autonomic nervous system during exercise. The baroreflex effectiveness index (BEI) and BRS will be estimated using the spontaneous sequence method. Briefly, the method casts about adjacent oscillations (ramps) in systolic blood pressure (SBP; > 1 mmHg) and RR and ( > 4 ms). BRS will be defined as the average of the BRS slopes. BEI will be calculated as the total number of BRS events divided by the total number of BP ramps observed during the 2-minute time-bin.
Statistical methods
Statistical tests will be performed in R (R studio Version 4.2.2). Descriptive statistics will be employed to analyze demographic and clinical variables measured at the baseline for each group. Categorical variables will be presented using frequencies and percentages, while continuous variables will be expressed as mean ± standard deviation (or median and range).
For the primary and secondary outcomes, data will undergo analysis using linear mixed models in R, and lme4. The fixed effects will be defined as the moment of intervention, and group, and the random intercept will be defined as each participant. Parameter estimation will utilize restricted maximal likelihood and the Kenward-Roger approximation for degrees of freedom will be applied for evaluating significance, ensuring optimal type I error rates. Secondary analyses will explore adjustments for protocol deviations through a per-protocol analysis. Post a significant interaction, pairwise comparisons will be conducted with a Bonferroni adjustment. For main and interaction effects, partial eta squared (η2) will be computed as an effect size estimate. Effect sizes for pairwise comparisons will be reported as Cohen's d, complemented by 95% confidence intervals for mean differences. All statistical analyses will be conducted using R software, with a significant level of α = 0.05.
- Conditions
- Coronary Arterial Disease (CAD)
- Being tested
- HIIT Intervention, MICT Intervention, HRV-Guided Intervention
- Keywords
- Exercise prescription, arterial stiffness, heart rate variability, autonomic activity, maximal oxygen consumption, moderate-intensity continuous training, high-intensity interval training
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HIIT InterventionOther
Over the first 4 weeks, participants will perform 4 bouts of 2 min of high-intensity exercise at 80-90% heart rate reserve (HRR), during the next 4 weeks, participants will perform 6 bouts of 2 min of high-intensity exercise at 80-90%HRR, while in the last 4 weeks participants will perform 6 bouts of 2 min of high-intensity exercise at 90%HRR). Exercise bouts will be interspersed by 2 min of active recovery at 50-60% HRR.
MICT InterventionOther
Over the first 4 weeks participants in MICT will perform continuous exercise at 50-60% HRR (2x10'), during the next 4 weeks participants will perform continuous exercise at 50-60% HRR (2x12'), while in the last 4 weeks participants will perform continuous exercise at 60-70% HRR (2x15').
HRV-Guided InterventionOther
Following a 10-day initial characterization period, where the HRV is measured with plethysmography continually during the night, with "Whoop" (https://www.whoop.com) device, the individual HRV profile is defined, still, participants will use the Whoop during all intervention to allow the updating of HRV profile. Then, considering the daily individual autonomic regulation, following a decision-making schema modified from Kiviniemi et al., (2007) [21], exercise intensity will be defined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (SWC = 0.5 × standard deviation), high intensity or moderate-intensity training sessions is prescribed, if LnRMSSD7day-roll-avg fell outside SWC, low intensity or rest is prescribed, leading to different workloads from the predefined training programs.
| Study group | Role | What they receive |
|---|---|---|
| HIIT (training/Behavioral) | Experimental | Over the first 4 weeks, participants will perform 4 bouts of 2 min of high-intensity exercise at 80-90% heart rate reserve (HRR), during the next 4 weeks, participants will perform 6 bouts of 2 min of high-intensity exercise at 80-90%HRR, while in the last 4 weeks participants will perform 6 bouts of 2 min of high-intensity exercise at 90%HRR). Exercise bouts will be interspersed by 2 min of active recovery at 50-60% HRR. Receives: Other: HIIT Intervention |
| MICT (training/Behavioral) | Experimental | Over the first 4 weeks participants in MICT will perform continuous exercise at 50-60% HRR (2x10'), during the next 4 weeks participants will perform continuous exercise at 50-60% HRR (2x12'), while in the last 4 weeks participants will perform continuous exercise at 60-70% HRR (2x15'). Receives: Other: MICT Intervention |
| HRV-Guided Training (training/Behavioral) | Experimental | Following a 10-day initial characterization period, where the HRV is measured with plethysmography continually during the night, with "Whoop" (https://www.whoop.com) device, the individual HRV profile is defined, still, participants will use the Whoop during all intervention to allow the updating of HRV profile. Then, considering the daily individual autonomic regulation, following a decision-making schema modified from Kiviniemi et al., (2007) [21], exercise intensity will be defined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (SWC = 0.5 × standard deviation), high intensity or moderate-intensity training sessions is prescribed, if LnRMSSD7day-roll-avg fell outside SWC, low intensity or rest is prescribed, leading to different workloads from the predefined training programs. Receives: Other: HRV-Guided Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cardiovagal modulation
The R-R intervals will be derived from beat-to-beat blood pressure pulse intervals using finger plethysmography (Finapres Nova, Amsterdam, Netherlands), during all measures. Finger plethysmography-derived peak-to-peak intervals are highly correlated with electrocardiogram R-R intervals, with similar variability. The upstroke is determined using the pressure signal with a resolution of 2 ms, and the interval between the two consecutive upstrokes is measured. In the frequency domain, the two primary components are low-frequency (LF: 0.04-0.15 Hz) and high-frequency (HF: 0.15-0.40 Hz) spectra. Heart rate variability measures provide information primarily on vagal modulation with the LF power spectrum reflecting both sympathetic and parasympathetic modulation and HF reflecting the parasympathetic modulation of the R-R intervals. The LF/HF ratio is used as an indicator of sympathovagal dominance.
Measured: pre and post intervention (12 weeks) assessments
Cardiorespiratory fitness
An incremental CPET will be performed on a treadmill (Pulsar 3p, HP Cosmos) with mixing-chamber gas exchange measurements (Quark RMR w/CPET, Italy), according to Bruce modified protocol. A 12-lead electrocardiogram will be continuously monitored, and blood pressure will be assessed by auscultation using an aneroid sphygmomanometer. A cardiologist and an exercise physiologist will supervise the CPET.
Before each test, the gas analyzer will be calibrated using ambient air standard calibration gases of known concentrations (16,7% O2 and 5,7% CO2). The turbine flowmeter of Cosmed will be calibrated with a 3L syringe. Data will be analyzed in 20 s average, and peak VO2 will be defined as the highest value attained in the last minute of effort
Measured: pre and post intervention (12 weeks) assessments
Secondary outcomes (3)
Baroreflex sensitivity
Spontaneous sequence method will be used to estimate BRS through the baroreflex module of FisioSinal [25]. This method emits about adjacent oscillations (ramps) in R-R and ( > 4 ms) and systolic blood pressure (SBP) (SBP; > 1 mmHg). Beat-to-beat SBP will be recorded using finger plethysmography (Finapres Measurement Systems, Amsterdam, Netherlands). A BRS event was defined as the overlap of BP ramps with concordant changes in R-R intervals. Hence, BRS will be defined as the average of the BRS slopes.
Measured: pre and post intervention (12 weeks) assessments
Local arterial stiffness
Carotid arterial stiffness indices will be assessed using eTRACKING technology (Arietta V60, Hitachi Aloka Medical Ltd, Mitaka-shi, Tokyo, Japan), using a 7.5 MHz linear array probe incorporating a 5 MHz Doppler transducer. In longitudinal view, the probe will be manipulated so that the intima of the artery is imaged clearly from both the anterior and posterior walls and a single scan line is aligned perpendicularly to the vessel walls at a site 20 mm proximal to the carotid bulb. On-screen cursors will be placed on the anterior and posterior intima-media borders to enable tracking of both walls. The corresponding displacement waveforms and diameter curve will be calculated using high-resolution online wall tracking ("E-track" technology), with a sampling rate of 1 kHz. Arterial pressure waveforms were obtained automatically in real-time by calibrating peak and bottom values with SBP and DBP measured with sphygmomanometry, as previously validated.
Measured: pre and post intervention (12 weeks) assessments
Regional Arterial Stiffness
Carotid femoral PWV, carotid-radial PWV, and femoral dorsalis PWV will be measured using a non-invasive automatic device (Complior, Alam Medical, France) with participants lied supine on a cushioned table. The common carotid artery, femoral, radial and dorsalis artery pressure waveforms will be recorded using 4 piezoelectric pressure mechanotransducers placed on each artery. The travel time distance will be defined as the tape measured distance over the body surface between the 2 recording sites of interest with distance being corrected by 0.8 factor for carotid femoral. All measurements will be performed by the same operator on the right side of the body after 10 pulse waveforms of enough quality (> 90%).
Measured: pre and post intervention (12 weeks) assessments
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2025
- Study start1 Sep 2025 (estimated)
- Primary completion1 Dec 2027 (estimated)
- Study completion1 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (34)Papers the sponsor has linked to this study.
- Other trials for Coronary Arterial Disease (CAD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 48 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Faculdade de Motricidade Humana
- Sponsor type
- University, hospital or other
- Collaborators
- Fundação para a Ciência e a Tecnologia
- Responsible party
- Principal investigator, Manuel Pedro, Faculdade de Motricidade Humana
- Investigators
- Helena Santa-Clara, PhD, Principal investigator, Faculdade de Motricidade Humana
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06919237
- Sponsor's protocol ID
- ParaDox
- Acronym
- ParaDox
- Status last verified
- Mar 2025
- First submitted
- 30 Mar 2025
- Last updated
- 9 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Carrasco-Poyatos M, Gonzalez-Quilez A, Altini M, Granero-Gallegos A. Heart rate variability-guided training in professional runners: Effects on performance and vagal modulation. Physiol Behav. 2022 Feb 1;244:113654. doi: 10.1016/j.physbeh.2021.113654. Epub 2021 Nov 20.
PubMed 34813821Khan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos AP, Georgiopoulou VV, Butler J, Laukkanen JA. Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study. Eur J Heart Fail. 2014 Feb;16(2):180-8. doi: 10.1111/ejhf.37. Epub 2013 Dec 14.
PubMed 24464981Kang SJ, Ko KJ. Association between resting heart rate, VO2max and carotid intima-media thickness in middle-aged men. Int J Cardiol Heart Vasc. 2019 Mar 29;23:100347. doi: 10.1016/j.ijcha.2019.100347. eCollection 2019 Jun.
PubMed 30976652Epelde F. Current Status, Challenges, and Future Directions in Cardiac Rehabilitation. Medicina (Kaunas). 2024 Feb 25;60(3):388. doi: 10.3390/medicina60030388.
PubMed 38541114Ribeiro PAB, Boidin M, Juneau M, Nigam A, Gayda M. High-intensity interval training in patients with coronary heart disease: Prescription models and perspectives. Ann Phys Rehabil Med. 2017 Jan;60(1):50-57. doi: 10.1016/j.rehab.2016.04.004. Epub 2016 Jun 23.
PubMed 27346629Pinto R, Angarten V, Santos V, Melo X, Santa-Clara H. The effect of an expanded long-term periodization exercise training on physical fitness in patients with coronary artery disease: study protocol for a randomized controlled trial. Trials. 2019 Apr 11;20(1):208. doi: 10.1186/s13063-019-3292-9.
PubMed 30975195Mattioni Maturana F, Soares RN, Murias JM, Schellhorn P, Erz G, Burgstahler C, Widmann M, Munz B, Thiel A, Niess AM. Responders and non-responders to aerobic exercise training: beyond the evaluation of V O2max. Physiol Rep. 2021 Aug;9(16):e14951. doi: 10.14814/phy2.14951.
PubMed 34409753Santa-Clara H, Fernhall B, Mendes M, Sardinha LB. Effect of a 1 year combined aerobic- and weight-training exercise programme on aerobic capacity and ventilatory threshold in patients suffering from coronary artery disease. Eur J Appl Physiol. 2002 Oct;87(6):568-75. doi: 10.1007/s00421-002-0675-4. Epub 2002 Jul 30.
PubMed 12355198Rakebrandt F, Palombo C, Swampillai J, Schon F, Donald A, Kozakova M, Kato K, Fraser AG. Arterial wave intensity and ventricular-arterial coupling by vascular ultrasound: rationale and methods for the automated analysis of forwards and backwards running waves. Ultrasound Med Biol. 2009 Feb;35(2):266-77. doi: 10.1016/j.ultrasmedbio.2008.08.013. Epub 2008 Nov 7.
PubMed 18992987Strauch AR, Berman MD, Miller HR. Substrate-associated macromolecules promote cytodifferentiation of BC3H1 myogenic cells. J Cell Physiol. 1991 Mar;146(3):337-48. doi: 10.1002/jcp.1041460302.
PubMed 1708777Ohte N, Saeki T, Miyabe H, Sakata S, Mukai S, Hayano J, Niki K, Sugawara M, Kimura G. Relationship between blood pressure obtained from the upper arm with a cuff-type sphygmomanometer and central blood pressure measured with a catheter-tipped micromanometer. Heart Vessels. 2007 Nov;22(6):410-5. doi: 10.1007/s00380-007-0998-5. Epub 2007 Nov 26.
PubMed 18044000Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
PubMed 8598068Conraads VM, Pattyn N, De Maeyer C, Beckers PJ, Coeckelberghs E, Cornelissen VA, Denollet J, Frederix G, Goetschalckx K, Hoymans VY, Possemiers N, Schepers D, Shivalkar B, Voigt JU, Van Craenenbroeck EM, Vanhees L. Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study. Int J Cardiol. 2015 Jan 20;179:203-10. doi: 10.1016/j.ijcard.2014.10.155. Epub 2014 Oct 25.
PubMed 25464446Pinto R, Melo X, Angarten V, Pires ML, Borges M, Santos V, Abreu A, Santa-Clara H. The effects of 12-months supervised periodized training on health-related physical fitness in coronary artery disease: a randomized controlled trial. J Sports Sci. 2021 Aug;39(16):1893-1902. doi: 10.1080/02640414.2021.1907062. Epub 2021 Mar 28.
PubMed 33775203Kiviniemi AM, Hautala AJ, Kinnunen H, Tulppo MP. Endurance training guided individually by daily heart rate variability measurements. Eur J Appl Physiol. 2007 Dec;101(6):743-51. doi: 10.1007/s00421-007-0552-2. Epub 2007 Sep 12.
PubMed 17849143
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Chronic Adaptations in Cardiovagal Modulation and Cardiorespiratory Fitness in Patients With Coronary Artery Disease to a 12-week Heart Rate Variability-guided Training vs Traditional Aerobic Prescription Program: Study Protocol for a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06919237
- Acronym / sponsor ID
- ParaDox / ParaDox
- Conditions
- Coronary Arterial Disease (CAD)
- Keywords
- Exercise prescription, arterial stiffness, heart rate variability, autonomic activity, maximal oxygen consumption, moderate-intensity continuous training, high-intensity interval training
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 48 participants (estimated)
- Lead sponsor
- Faculdade de Motricidade HumanaUniversity, hospital or other
- Collaborators
- Fundação para a Ciência e a Tecnologia
- Study start
- 1 Sep 2025 (estimated)
- Primary completion
- 1 Dec 2027 (estimated)
- Study completion
- 1 Jun 2028 (estimated)
- First posted
- 9 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Coronary artery disease (CAD) is associated with autonomic dysfunction and is characterized by reduced heart rate variability (HRV) and impaired heart rate recovery. Regular exercise improves cardiovascular outcomes in CAD, with high-intensity interval training (HIIT) showing superior benefits compared to moderate-intensity continuous training (MICT). However, the full potential of exercise is not used in the clinical context since some of the training principles are neglected, contributing to a high number of exercise non-responders. HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise and has contributed to greater improvements compared to standard prescriptions. Thus, this study aims to assess the chronic effects of exercise on cardiovagal modulation, baroreflex sensitivity, arterial stiffness, and cardiorespiratory fitness in patients with CAD, specifically determining whether heart rate variability-guided training yields different outcomes compared to a traditional prescription in a 12-week exercise intervention.
A total of 48 participants, will be recruited and randomized into one of 3 groups: high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), and HRV-guided training. The intervention will consist of 12 weeks of supervised exercise, with 3 weekly sessions. Participants in the HRV-guided training group will have their exercise intensity adjusted based on their individual HRV profiles. Moderate- or high-intensity sessions are prescribed when the 7-day rolling average of LnRMSSD remains within the smallest worthwhile change (SWC). If it falls outside the SWC, low-intensity sessions or rest are recommended. In the HIIT group, sessions will consist of 4 bouts of 2 minutes at 80-90% HRR during the first 4 weeks, increasing to 6 bouts of 2 minutes at the same intensity in weeks 5-8, and progressing to 6 bouts of 2 minutes at 90% HRR in the final 4 weeks. In the MICT group, participants will perform continuous sessions starting with 2x10 minutes at 50-60% HRR in the first 4 weeks, progressing to 2x12 minutes at the same intensity in weeks 5-8, and increasing to 2x15 minutes at 60-70% HRR in the final phase. Cardiovagal modulation, cardiorespiratory fitness, BRS, and AS will be assessed at the baseline and after the 12 weeks of intervention.
Most cardiac rehabilitation programs use the "one-size-fits-all" approach, which is a limitation of the literature, leading to a large number of exercise nonresponders to changes in cardiorespiratory fitness. HRV-guided training seems to be a more individualized method of aerobic prescription and may lead to greater improvements in cardiorespiratory fitness and in cardiovagal modulation. This study will contribute to generate evidence regarding aerobic exercise prescription in cardiac rehabilitation.
Detailed description
Background
Coronary artery disease (CAD) is characterized by the inability to adequately supply blood and oxygen to the heart, often resulting from the formation of atherosclerotic plaques within the arterial lumen. This inflammatory, multifactorial condition can impair the autonomic nervous system (ANS), disrupting the balance between the sympathetic and parasympathetic pathways and leading to autonomic dysfunction. Key indicators of this dysfunction include reduced heart rate variability (HRV) and delayed heart rate recovery, both of which signify heightened sympathetic activity and diminished parasympathetic activity. These changes predict worse cardiovascular outcomes in CAD patients, as the ANS compensates for myocardial ischemia and hypoxia by increasing sympathetic drive and reducing vagal activity to preserve cardiac contractility and output. This imbalance triggers a cascade of neurohumoral alterations affecting the cardiovascular, peripheral vascular, and renal systems, further exacerbating disease progression.
Regular exercise is known to play an important role in the prevention, management, and treatment of CAD, mainly through the preservation of endothelial function but also through the improvement of cardiovagal modulation and neurocardiovascular stress reactivity and by the increase in cardiorespiratory fitness. Patients with stable CAD should undergo a cardiac rehabilitation program to fulfill exercise guidelines. Protocols may vary in mode, intensity, frequency, and duration, whereas the most recommended types of exercise are walking and cycling, with intensities between 40-80% of VO2peak associated with increases in exercise capacity by 11-36%. Recent studies demonstrated that high-intensity interval training (HIIT) compared with moderate-intensity continuous training (MICT) promotes higher adaptation in VO2max and in post-exercise heart rate recovery, HIIT has also demonstrated to contribute to the restoration of endothelial function and autonomic balance, inducing reverse cardiac remodeling and increasing left ventricle morphology and function. However, MICT demonstrates higher adherence because it is a safer and more effective approach. Nevertheless, despite the known non-pharmacological benefits of exercise, recent studies demonstrate that more than 15% of the patients with CAD are exercise non-responders to increases in VO2max , i.e., an increase of 3.5 ml/kg/min in VO2max, which has been associated with a 10% decrease in all-cause of mortality and cardiovascular mortality, however the greater the increases in VO2max the greater the reduction in the risk.
Exercise individualization is increasing among apparently healthy populations due to the ease of the use of cellphone applications. Recently, HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise prescription, this prescription technique demonstrated to contribute to greater improvements in endurance athletes. HRV-guided training concerns to exercise prescribed based on daily changes in HRV, depending on thresholds constructed at the individual level. After an initial characterization period, where the HRV after waking up is measured, the individual HRV profile is defined. Then, considering the resting values of HRV, exercise intensity will be determined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (+), high-intensity or moderate-intensity training sessions is prescribed, and if LnRMSSD7day-roll-avg fell outside SWC (-), low intensity or rest is prescribed. This prescription technique leads to different workloads from the predefined training programs.
To the best of our knowledge, no study has yet compared the chronic effects of two different exercise protocols on cardiovagal modulation, and cardiorespiratory fitness in patients with CAD. Thus, this research aims to compare the chronic adaptations on cardiorespiratory fitness, cardiovagal modulation, baroreflex sensitivity (BRS), and arterial stiffness (AS) of two different techniques of exercise prescription (traditional vs individualized) and two training methods (HIIT vs MICT) in patients with CAD. We hypothesize that exercise individualization will promote higher adaptations in cardiovagal modulation, cardiorespiratory fitness, BRS and AS in patients with CAD, compared with traditional prescription.
Methods
Study design This longitudinal randomized trial will consist of comparing the effects of different exercise prescription techniques and different methods of exercise prescription (traditional MICT, traditional HIIT, and HRV-guided training) would exhibit differences in chronic adaptations in cardiorespiratory fitness, cardiovagal modulation, and BRS in patients with CAD. The study will consist of 12 weeks of supervised exercise with 3 sessions per week. This study protocol was submitted to the Faculty of Human Kinetics Institutional Review Board.
Sample size
Assuming a change in VO2max of 3.5 mL/kg/min to be clinically relevant, α = 0.05, 1-β = 0.80, an expected dropout of 15% for 12 weeks, and a chosen medium effect size of 0.25 due to gaps in the literature, the calculations yielded a total minimum of 48 participants (16 per group) (G*Power, version 3.1.9.4), however, the sample size will be updated, if necessary, after a pilot study consisting of 12 participants, 4 per group, (48x0.25=12).
Recruitment
Recruitment will be performed mainly at the Coronary Club of Lisbon (CORLIS) (phase III) at the Faculty of Human Kinetics and at the Hospital of Santa Cruz in Lisbon.
Measurements
All study measurements will be collected at the Faculty of Human Kinetics, University of Lisbon. Assessments of cardiopulmonary exercise test (CPET), cardiovagal modulation, body composition, and arterial stiffness, will be conducted both at baseline and after the 12-week intervention period. Participants will be requested to be fasted (> 4h), abstain from foods/drinks containing caffeine and alcohol (> 12h), and refrain from strenuous exercise (> 24h) before assessments, post-intervention assessments will be scheduled for the same time that baseline. The measures will follow the following order body composition, cardiovagal modulation (and baroreflex sensitivity), local and regional arterial stiffness, cardiopulmonary test, and post-maximal exercise cardiovagal modulation (and baroreflex sensitivity), and local and regional arterial stiffness.
Randomization
Baseline evaluation will be done before randomization, thus neither participants nor fieldwork staff will know the group assignment at this point. Due to the nature of the intervention, it will not be possible to blind participants after baseline assessments. After the baseline assessments, block randomization by group with balanced blocks of 12 participants will be performed by a researcher not involved in recruitment or data collection using REDCap (https://imm.medicina.ulisboa.pt/group/redcap/redcap_v7.6.7/). The participants will be randomly allocated to one of the three groups: HIIT, MICT, and HRV-guided training.
Exercise intervention
Exercise intervention will have a 12-week duration, with 3 sessions per week on non-consecutive days for all 3 groups and will be carried out at the Faculdade de Motricidade Humana. Certified exercise physiologists will supervise sessions. Heart rate will be monitored during all sessions with an HR monitor (S810i Polar, Polar Electro, Kempele, Finland; sampling rate 1000 Hz). All sessions will include a 10-minute warm-up, an aerobic component, a strength component, and a cool-down for both groups. The warm-up will focus on increasing HR, improving mobility, and performing preparatory stretches for the conditioning component. The strength component will consist of 6 arm and 2 leg machines with 2 sets of 8 to 12 reps at 50-60% 1RM per machine. The cool-down will transition from the conditioning component to the stretching phase, consisting of static and dynamic stretching exercises for all major muscle groups. Warm-up, strength component and coold-down will be standardized for the 3 groups. Sessions will be deemed completed when at least 83.3% (30 out of 36 sessions i.e. minimum adherence = 83.3%) of the prescribed exercise sessions have been successfully performed (reached the programmed intensity). The aerobic component in all groups will follow linear periodization. Volume and/or intensity will increase every 4 weeks.
Data analysis
All HRV analyses will be performed offline using the FisioSinal software built-in Matlab [25]. Time-domain and spectral power analyses will be conducted using 2-min time bins. Ectopic heartbeats (M = 1, SD = 4 b.min-1) will be excluded from the final analysis. The time-domain statistics used to characterize HRV will be SDNN and RMSSD. Non-linear time-domain parameters will be derived from the Poincaré plot including SD1 and SD2. The time-frequency domain analysis will be conducted using the Daubechy-12 discrete wavelet algorithm. Wavelet analysis will be chosen instead of fast Fourier transform as it is better suited to characterize the acute responses of the autonomic nervous system during exercise. The baroreflex effectiveness index (BEI) and BRS will be estimated using the spontaneous sequence method. Briefly, the method casts about adjacent oscillations (ramps) in systolic blood pressure (SBP; > 1 mmHg) and RR and ( > 4 ms). BRS will be defined as the average of the BRS slopes. BEI will be calculated as the total number of BRS events divided by the total number of BP ramps observed during the 2-minute time-bin.
Statistical methods
Statistical tests will be performed in R (R studio Version 4.2.2). Descriptive statistics will be employed to analyze demographic and clinical variables measured at the baseline for each group. Categorical variables will be presented using frequencies and percentages, while continuous variables will be expressed as mean ± standard deviation (or median and range).
For the primary and secondary outcomes, data will undergo analysis using linear mixed models in R, and lme4. The fixed effects will be defined as the moment of intervention, and group, and the random intercept will be defined as each participant. Parameter estimation will utilize restricted maximal likelihood and the Kenward-Roger approximation for degrees of freedom will be applied for evaluating significance, ensuring optimal type I error rates. Secondary analyses will explore adjustments for protocol deviations through a per-protocol analysis. Post a significant interaction, pairwise comparisons will be conducted with a Bonferroni adjustment. For main and interaction effects, partial eta squared (η2) will be computed as an effect size estimate. Effect sizes for pairwise comparisons will be reported as Cohen's d, complemented by 95% confidence intervals for mean differences. All statistical analyses will be conducted using R software, with a significant level of α = 0.05.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| HIIT (training/Behavioral) | Experimental | Other: HIIT InterventionOver the first 4 weeks, participants will perform 4 bouts of 2 min of high-intensity exercise at 80-90% heart rate reserve (HRR), during the next 4 weeks, participants will perform 6 bouts of 2 min of high-intensity exercise at 80-90%HRR, while in the last 4 weeks participants will perform 6 bouts of 2 min of high-intensity exercise at 90%HRR). Exercise bouts will be interspersed by 2 min of active recovery at 50-60% HRR. |
| MICT (training/Behavioral) | Experimental | Other: MICT InterventionOver the first 4 weeks participants in MICT will perform continuous exercise at 50-60% HRR (2x10'), during the next 4 weeks participants will perform continuous exercise at 50-60% HRR (2x12'), while in the last 4 weeks participants will perform continuous exercise at 60-70% HRR (2x15'). |
| HRV-Guided Training (training/Behavioral) | Experimental | Other: HRV-Guided InterventionFollowing a 10-day initial characterization period, where the HRV is measured with plethysmography continually during the night, with "Whoop" (https://www.whoop.com) device, the individual HRV profile is defined, still, participants will use the Whoop during all intervention to allow the updating of HRV profile. Then, considering the daily individual autonomic regulation, following a decision-making schema modified from Kiviniemi et al., (2007) [21], exercise intensity will be defined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (SWC = 0.5 × standard deviation), high intensity or moderate-intensity training sessions is prescribed, if LnRMSSD7day-roll-avg fell outside SWC, low intensity or rest is prescribed, leading to different workloads from the predefined training programs. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- aged over 18 years;
- had angiographically documented CAD in at least one major epicardial vessel;
- clinical evidence of CAD in the form of previous myocardial infarction;
- clinical evidence of CAD in the form of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention);
- clinical evidence of CAD in the form of angina pectoris.
Key exclusion criteria (4 listed)
- heart failure;
- cardiac implantable defibrillators;
- resynchronizing devices;
- inability to comply with guidelines for participation in exercise testing and training.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HIIT InterventionOver the first 4 weeks, participants will perform 4 bouts of 2 min of high-intensity exercise at 80-90% heart rate reserve (HRR), during the next 4 weeks, participants will perform 6 bouts of 2 min of high-intensity exercise at 80-90%HRR, while in the last 4 weeks participants will perform 6 bouts of 2 min of high-intensity exercise at 90%HRR). Exercise bouts will be interspersed by 2 min of active recovery at 50-60% HRR. | Other | HIIT (training/Behavioral) |
| MICT InterventionOver the first 4 weeks participants in MICT will perform continuous exercise at 50-60% HRR (2x10'), during the next 4 weeks participants will perform continuous exercise at 50-60% HRR (2x12'), while in the last 4 weeks participants will perform continuous exercise at 60-70% HRR (2x15'). | Other | MICT (training/Behavioral) |
| HRV-Guided InterventionFollowing a 10-day initial characterization period, where the HRV is measured with plethysmography continually during the night, with "Whoop" (https://www.whoop.com) device, the individual HRV profile is defined, still, participants will use the Whoop during all intervention to allow the updating of HRV profile. Then, considering the daily individual autonomic regulation, following a decision-making schema modified from Kiviniemi et al., (2007) [21], exercise intensity will be defined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (SWC = 0.5 × standard deviation), high intensity or moderate-intensity training sessions is prescribed, if LnRMSSD7day-roll-avg fell outside SWC, low intensity or rest is prescribed, leading to different workloads from the predefined training programs. | Other | HRV-Guided Training (training/Behavioral) |
Primary outcome
Cardiovagal modulation
Time frame: pre and post intervention (12 weeks) assessments
The R-R intervals will be derived from beat-to-beat blood pressure pulse intervals using finger plethysmography (Finapres Nova, Amsterdam, Netherlands), during all measures. Finger plethysmography-derived peak-to-peak intervals are highly correlated with electrocardiogram R-R intervals, with similar variability. The upstroke is determined using the pressure signal with a resolution of 2 ms, and the interval between the two consecutive upstrokes is measured. In the frequency domain, the two primary components are low-frequency (LF: 0.04-0.15 Hz) and high-frequency (HF: 0.15-0.40 Hz) spectra. Heart rate variability measures provide information primarily on vagal modulation with the LF power spectrum reflecting both sympathetic and parasympathetic modulation and HF reflecting the parasympathetic modulation of the R-R intervals. The LF/HF ratio is used as an indicator of sympathovagal dominance.
Cardiorespiratory fitness
Time frame: pre and post intervention (12 weeks) assessments
An incremental CPET will be performed on a treadmill (Pulsar 3p, HP Cosmos) with mixing-chamber gas exchange measurements (Quark RMR w/CPET, Italy), according to Bruce modified protocol. A 12-lead electrocardiogram will be continuously monitored, and blood pressure will be assessed by auscultation using an aneroid sphygmomanometer. A cardiologist and an exercise physiologist will supervise the CPET. Before each test, the gas analyzer will be calibrated using ambient air standard calibration gases of known concentrations (16,7% O2 and 5,7% CO2). The turbine flowmeter of Cosmed will be calibrated with a 3L syringe. Data will be analyzed in 20 s average, and peak VO2 will be defined as the highest value attained in the last minute of effort
3 secondary outcomes
Baroreflex sensitivity
Time frame: pre and post intervention (12 weeks) assessments
Local arterial stiffness
Time frame: pre and post intervention (12 weeks) assessments
Regional Arterial Stiffness
Time frame: pre and post intervention (12 weeks) assessments
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2025.
- Background: PubMed 34813821Carrasco-Poyatos M, Gonzalez-Quilez A, Altini M, Granero-Gallegos A. Heart rate variability-guided training in professional runners: Effects on performance and vagal modulation. Physiol Behav. 2022 Feb 1;244:113654. doi: 10.1016/j.physbeh.2021.113654. Epub 2021 Nov 20.
- Background: PubMed 24464981Khan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos AP, Georgiopoulou VV, Butler J, Laukkanen JA. Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study. Eur J Heart Fail. 2014 Feb;16(2):180-8. doi: 10.1111/ejhf.37. Epub 2013 Dec 14.
- Background: PubMed 30976652Kang SJ, Ko KJ. Association between resting heart rate, VO2max and carotid intima-media thickness in middle-aged men. Int J Cardiol Heart Vasc. 2019 Mar 29;23:100347. doi: 10.1016/j.ijcha.2019.100347. eCollection 2019 Jun.
- Background: PubMed 38541114Epelde F. Current Status, Challenges, and Future Directions in Cardiac Rehabilitation. Medicina (Kaunas). 2024 Feb 25;60(3):388. doi: 10.3390/medicina60030388.
- Background: PubMed 27346629Ribeiro PAB, Boidin M, Juneau M, Nigam A, Gayda M. High-intensity interval training in patients with coronary heart disease: Prescription models and perspectives. Ann Phys Rehabil Med. 2017 Jan;60(1):50-57. doi: 10.1016/j.rehab.2016.04.004. Epub 2016 Jun 23.
- Background: PubMed 30975195Pinto R, Angarten V, Santos V, Melo X, Santa-Clara H. The effect of an expanded long-term periodization exercise training on physical fitness in patients with coronary artery disease: study protocol for a randomized controlled trial. Trials. 2019 Apr 11;20(1):208. doi: 10.1186/s13063-019-3292-9.
- Background: PubMed 34409753Mattioni Maturana F, Soares RN, Murias JM, Schellhorn P, Erz G, Burgstahler C, Widmann M, Munz B, Thiel A, Niess AM. Responders and non-responders to aerobic exercise training: beyond the evaluation of V O2max. Physiol Rep. 2021 Aug;9(16):e14951. doi: 10.14814/phy2.14951.
- Background: PubMed 12355198Santa-Clara H, Fernhall B, Mendes M, Sardinha LB. Effect of a 1 year combined aerobic- and weight-training exercise programme on aerobic capacity and ventilatory threshold in patients suffering from coronary artery disease. Eur J Appl Physiol. 2002 Oct;87(6):568-75. doi: 10.1007/s00421-002-0675-4. Epub 2002 Jul 30.
- Background: PubMed 18992987Rakebrandt F, Palombo C, Swampillai J, Schon F, Donald A, Kozakova M, Kato K, Fraser AG. Arterial wave intensity and ventricular-arterial coupling by vascular ultrasound: rationale and methods for the automated analysis of forwards and backwards running waves. Ultrasound Med Biol. 2009 Feb;35(2):266-77. doi: 10.1016/j.ultrasmedbio.2008.08.013. Epub 2008 Nov 7.
- Background: PubMed 1708777Strauch AR, Berman MD, Miller HR. Substrate-associated macromolecules promote cytodifferentiation of BC3H1 myogenic cells. J Cell Physiol. 1991 Mar;146(3):337-48. doi: 10.1002/jcp.1041460302.
- Background: PubMed 18044000Ohte N, Saeki T, Miyabe H, Sakata S, Mukai S, Hayano J, Niki K, Sugawara M, Kimura G. Relationship between blood pressure obtained from the upper arm with a cuff-type sphygmomanometer and central blood pressure measured with a catheter-tipped micromanometer. Heart Vessels. 2007 Nov;22(6):410-5. doi: 10.1007/s00380-007-0998-5. Epub 2007 Nov 26.
- Background: PubMed 8598068Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
Related trials for Coronary Arterial Disease (CAD)
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
RecruitingObservational study
Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
Coronary Artery Disease, Left Ventricular Systolic Dysfunction
Active, not recruiting
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
Ischaemic Heart Disease, Ischemic Heart Disease
RecruitingEarly Phase 1
Thiamine Intervention and Coronary Artery Bypass Grafting
Coronary Heart Disease, Coronary Artery Bypass Grafting
Not yet recruitingObservational study
Preoperative Gastric Ultrasound and Anaesthetic Management in Patients Undergoing Coronary Artery Bypass Grafting
Preoperative Fasting, Pulmonary Aspiration During Anesthetic Induction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Helena Santa-Clara, PhD principal investigator
Faculdade de Motricidade Humana
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing HIIT Intervention, MICT Intervention and HRV-Guided Intervention in people with Coronary Arterial Disease (CAD), run by Faculdade de Motricidade Humana at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Manuel Pedro, Masters (+ 351 966973481, mpedro661@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cardiovagal modulation (time frame: pre and post intervention (12 weeks) assessments). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06919237, which also lists 34 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2025.